Control of hepatic glucose metabolism by islet and brain

Diabetes, Obesity and Metabolism

Volumn 16, Issue , 2014, Pages 33-40

  Rojas, J M ^a   Schwartz, Michael W ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Hepatic glucose production; Hepatic glucose uptake; Hypothalamus; Obesity; Pancreas; Type 2 diabetes

Indexed keywords

GLUCOSE; INSULIN; INSULIN RECEPTOR SUBSTRATE;

BRAIN; DRUG MECHANISM; GLUCONEOGENESIS; GLUCOSE METABOLISM; GLUCOSE TRANSPORT; HEPATIC GLUCOSE UPTAKE; HUMAN; LIVER; NONHUMAN; PANCREAS ISLET; REVIEW; AGONISTS; ANIMAL; BIOLOGICAL MODEL; FEEDBACK SYSTEM; GLYCOLYSIS; INNERVATION; METABOLISM; NERVE CELL; SECRETION (PROCESS); SIGNAL TRANSDUCTION;

ANIMALS; BRAIN; FEEDBACK, PHYSIOLOGICAL; GLUCONEOGENESIS; GLUCOSE; GLYCOLYSIS; HUMANS; INSULIN; INSULIN RECEPTOR SUBSTRATE PROTEINS; ISLETS OF LANGERHANS; LIVER; MODELS, BIOLOGICAL; NEURONS; SIGNAL TRANSDUCTION;

EID: 84908555563     PISSN: 14628902     EISSN: 14631326     Source Type: Journal    
DOI: 10.1111/dom.12332     Document Type: Review

References (62)

1. Ogden CL, Carroll MD, Curtin LR, McDowell MA, Tabak CJ, Flegal KM. Prevalence of overweight and obesity in the United States, 1999-2004. JAMA 2006; 295: 1549-1555.
2. Cowie CC, Rust KF, Byrd-Holt DD et al. Prevalence of diabetes and impaired fasting glucose in adults in the U.S. population: National Health and Nutrition Examination Survey 1999-2002. Diabetes Care 2006; 29: 1263-1268.
3. Harris MI. Diabetes in America: epidemiology and scope of the problem. Diabetes Care 1998; 21(Suppl. 3): C11-C14.
4. Hossain P, Kawar B, El Nahas M. Obesity and diabetes in the developing world-a growing challenge. N Engl J Med 2007; 356: 213-215.
5. DeFronzo RA, Bonadonna RC, Ferrannini E. Pathogenesis of NIDDM. A balanced overview. Diabetes Care 1992; 15: 318-368.
6. Moore MC, Coate KC, Winnick JJ, An Z, Cherrington AD. Regulation of hepatic glucose uptake and storage in vivo. Adv Nutr 2012; 3: 286-294.
7. Bernard C. Leçons de physiologie expérimentale appliquées á la médecine. Paris: Baillère et Fils, 1854.
8. Mayer J. Glucostatic mechanism of regulation of food intake. 1953. Obes Res 1996; 4: 493-496.
9. Oomura Y, Ono T, Ooyama H, Wayner MJ. Glucose and osmosensitive neurones of the rat hypothalamus. Nature 1969; 222: 282-284.
10. Borg MA, Sherwin RS, Borg WP, Tamborlane WV, Shulman GI. Local ventromedial hypothalamus glucose perfusion blocks counterregulation during systemic hypoglycemia in awake rats. J Clin Invest 1997; 99: 361-365.
11. Borg MA, Tamborlane WV, Shulman GI, Sherwin RS. Local lactate perfusion of the ventromedial hypothalamus suppresses hypoglycemic counterregulation. Diabetes 2003; 52: 663-666.
12. Mittelman SD, Fu YY, Rebrin K, Steil G, Bergman RN. Indirect effect of insulin to suppress endogenous glucose production is dominant, even with hyperglucagonemia. J Clin Invest 1997; 100: 3121-3130.
13. Ader M, Bergman RN. Peripheral effects of insulin dominate suppression of fasting hepatic glucose production. Am J Physiol 1990; 258: E1020-E1032.
14. Lewis GF, Zinman B, Groenewoud Y, Vranic M, Giacca A. Hepatic glucose production is regulated both by direct hepatic and extrahepatic effects of insulin in humans. Diabetes 1996; 45: 454-462.
15. Ito K, Maruyama H, Hirose H et al. Exogenous insulin dose-dependently suppresses glucopenia-induced glucagon secretion from perfused rat pancreas. Metabolism 1995; 44: 358-362.
16. Lewis GF, Vranic M, Giacca A. Glucagon enhances the direct suppressive effect of insulin on hepatic glucose production in humans. Am J Physiol 1997; 272: E371-E378.
17. Giacca A, Fisher SJ, McCall RH, Shi ZQ, Vranic M. Direct and indirect effects of insulin in suppressing glucose production in depancreatized dogs: role of glucagon. Endocrinology 1997; 138: 999-1007.
18. Sindelar DK, Chu CA, Venson P, Donahue EP, Neal DW, Cherrington AD. Basal hepatic glucose production is regulated by the portal vein insulin concentration. Diabetes 1998; 47: 523-529.
19. Sindelar DK, Balcom JH, Chu CA, Neal DW, Cherrington AD. A comparison of the effects of selective increases in peripheral or portal insulin on hepatic glucose production in the conscious dog. Diabetes 1996; 45: 1594-1604.
20. Lewis GF, Vranic M, Harley P, Giacca A. Fatty acids mediate the acute extrahepatic effects of insulin on hepatic glucose production in humans. Diabetes 1997; 46: 1111-1119.
21. Sindelar DK, Chu CA, Rohlie M, Neal DW, Swift LL, Cherrington AD. The role of fatty acids in mediating the effects of peripheral insulin on hepatic glucose production in the conscious dog. Diabetes 1997; 46: 187-196.
22. Pocai A, Lam TK, Gutierrez-Juarez R et al. Hypothalamic K (ATP) channels control hepatic glucose production. Nature 2005; 434: 1026-1031.
23. Scherer T, O'Hare J, Diggs-Andrews K et al. Brain insulin controls adipose tissue lipolysis and lipogenesis. Cell Metab 2011; 13: 183-194.
24. Koch L, Wunderlich FT, Seibler J et al. Central insulin action regulates peripheral glucose and fat metabolism in mice. J Clin Invest 2008; 118: 2132-2147.
25. Paranjape SA, Chan O, Zhu W et al. Influence of insulin in the ventromedial hypothalamus on pancreatic glucagon secretion in vivo. Diabetes 2010; 59: 1521-1527.
26. Ramnanan CJ, Edgerton DS, Cherrington AD. Evidence against a physiologic role for acute changes in CNS insulin action in the rapid regulation of hepatic glucose production. Cell Metab 2012; 15: 656-664.
27. Whiteman EL, Cho H, Birnbaum MJ. Role of Akt/protein kinase B in metabolism. Trends Endocrinol Metab 2002; 13: 444-451.
28. Sarbassov DD, Guertin DA, Ali SM, Sabatini DM. Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex. Science 2005; 307: 1098-1101.
29. Huang J, Manning BD. A complex interplay between Akt, TSC2 and the two mTOR complexes. Biochem Soc Trans 2009; 37: 217-222.
30. Cho H, Mu J, Kim JK et al. Insulin resistance and a diabetes mellitus-like syndrome in mice lacking the protein kinase Akt2 (PKB beta). Science 2001; 292: 1728-1731.
31. Fayard E, Tintignac LA, Baudry A, Hemmings BA. Protein kinase B/Akt at a glance. J Cell Sci 2005; 118: 5675-5678.
32. Nakae J, Oki M, Cao Y. The FoxO transcription factors and metabolic regulation. FEBS Lett 2008; 582: 54-67.
33. Lu M, Wan M, Leavens KF et al. Insulin regulates liver metabolism in vivo in the absence of hepatic Akt and Foxo1. Nat Med 2012; 18: 388-395.
34. Michael MD, Kulkarni RN, Postic C et al. Loss of insulin signaling in hepatocytes leads to severe insulin resistance and progressive hepatic dysfunction. Mol Cell 2000; 6: 87-97.
35. Cherrington AD. Banting Lecture 1997. Control of glucose uptake and release by the liver in vivo. Diabetes 1999; 48: 1198-1214.
36. Schwartz MW, Figlewicz DP, Baskin DG, Woods SC, Porte D Jr. Insulin in the brain: a hormonal regulator of energy balance. Endocr Rev 1992; 13: 387-414.
37. Chen M, Woods SC, Porte D Jr. Effect of cerebral intraventricular insulin on pancreatic insulin secretion in the dog. Diabetes 1975; 24: 910-914.
38. Woods SC, Porte D Jr. Effect of intracisternal insulin on plasma glucose and insulin in the dog. Diabetes 1975; 24: 905-909.
39. Obici S, Feng Z, Karkanias G, Baskin DG, Rossetti L. Decreasing hypothalamic insulin receptors causes hyperphagia and insulin resistance in rats. Nat Neurosci 2002; 5: 566-572.
40. Obici S, Zhang BB, Karkanias G, Rossetti L. Hypothalamic insulin signaling is required for inhibition of glucose production. Nat Med 2002; 8: 1376-1382.
41. Filippi BM, Yang CS, Tang C, Lam TK. Insulin activates Erk1/2 signaling in the dorsal vagal complex to inhibit glucose production. Cell Metab 2012; 16: 500-510.
42. Konner AC, Janoschek R, Plum L et al. Insulin action in AgRP-expressing neurons is required for suppression of hepatic glucose production. Cell Metab 2007; 5: 438-449.
43. Inoue H, Ogawa W, Asakawa A et al. Role of hepatic STAT3 in brain-insulin action on hepatic glucose production. Cell Metab 2006; 3: 267-275.
44. Gelling RW, Morton GJ, Morrison CD et al. Insulin action in the brain contributes to glucose lowering during insulin treatment of diabetes. Cell Metab 2006; 3: 67-73.
45. Chinookoswong N, Wang JL, Shi ZQ. Leptin restores euglycemia and normalizes glucose turnover in insulin-deficient diabetes in the rat. Diabetes 1999; 48: 1487-1492.
46. Yu X, Park BH, Wang MY, Wang ZV, Unger RH. Making insulin-deficient type 1 diabetic rodents thrive without insulin. PNAS 2008; 105: 14070-14075.
47. German JP, Thaler JP, Wisse BE et al. Leptin activates a novel CNS mechanism for insulin-independent normalization of severe diabetic hyperglycemia. Endocrinology 2011; 152: 394-404.
48. Schwartz MW, Seeley RJ, Tschop MH et al. Cooperation between brain and islet in glucose homeostasis and diabetes. Nature 2013; 503: 59-66.
49. Bruning JC, Gautam D, Burks DJ et al. Role of brain insulin receptor in control of body weight and reproduction. Science 2000; 289: 2122-2125.
50. Edgerton DS, Lautz M, Scott M et al. Insulin's direct effects on the liver dominate the control of hepatic glucose production. J Clin Invest 2006; 116: 521-527.
51. Ramnanan CJ, Saraswathi V, Smith MS et al. Brain insulin action augments hepatic glycogen synthesis without suppressing glucose production or gluconeogenesis in dogs. J Clin Invest 2011; 121: 3713-3723.
52. Buettner C, Patel R, Muse ED et al. Severe impairment in liver insulin signaling fails to alter hepatic insulin action in conscious mice. J Clin Invest 2005; 115: 1306-1313.
53. Okamoto H, Obici S, Accili D, Rossetti L. Restoration of liver insulin signaling in Insr knockout mice fails to normalize hepatic insulin action. J Clin Invest 2005; 115: 1314-1322.
54. Lin HV, Plum L, Ono H et al. Divergent regulation of energy expenditure and hepatic glucose production by insulin receptor in agouti-related protein and POMC neurons. Diabetes 2010; 59: 337-346.
55. Cherrington AD. The role of hepatic insulin receptors in the regulation of glucose production. J Clin Invest 2005; 115: 1136-1139.
56. Hendrick GK, Frizzell RT, Williams PE, Cherrington AD. Effect of hyperglucagonemia on hepatic glycogenolysis and gluconeogenesis after a prolonged fast. Am J Physiol 1990; 258: E841-E849.
57. Nuttall FQ, Ngo A, Gannon MC. Regulation of hepatic glucose production and the role of gluconeogenesis in humans: is the rate of gluconeogenesis constant? Diabetes Metab Res Rev 2008; 24: 438-458.
58. Kokubun E, Hirabara SM, Fiamoncini J, Curi R, Haebisch H. Changes of glycogen content in liver, skeletal muscle, and heart from fasted rats. Cell Biochem Funct 2009; 27: 488-495.
59. Ramnanan CJ, Kraft G, Smith MS et al. Interaction between the central and peripheral effects of insulin in controlling hepatic glucose metabolism in the conscious dog. Diabetes 2013; 62: 74-84.
60. Coate KC, Kraft G, Irimia JM et al. Portal vein glucose entry triggers a coordinated cellular response that potentiates hepatic glucose uptake and storage in normal but not high-fat/high-fructose-fed dogs. Diabetes 2013; 62: 392-400.
61. Morton GJ, Matsen ME, Bracy DP et al. FGF19 action in the brain induces insulin-independent glucose lowering. J Clin Invest 2013; 123: 4799-4808.
62. Best JD, Kahn SE, Ader M, Watanabe RM, Ni TC, Bergman RN. Role of glucose effectiveness in the determination of glucose tolerance. Diabetes Care 1996; 19: 1018-1030.